| Name | Title | Contact Details |
|---|
Biorez is dedicated to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We have developed the BioBrace™ scaffold, a new implant technology to reinforce tendon and ligament repairs and to facilitate tissue regeneration. Through our proprietary open porous architecture, and use of biomaterials, the BioBrace™ has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state. Early pre-clinical work suggests the BioBrace will deliver on the promise of a superior tissue scaffold to accelerate rehabilitation, regenerate functional tissue, and improve overall outcomes. Biorez is a VC-backed startup located in New Haven, CT.
Our dedicated teams work together to create healthier communities by building strong partnerships. We connect expertise to inspired ideas, products and services while creating a relevant, memorable difference in the lives of our clients, customers and employees. Our dental division provides differentiated products, services and solutions throughout North America. We partner with oral health professionals to create an improved patient experience and practice lifestyle. Our animal health division provides consumable supplies, equipment, software, diagnostic products, vaccines and pharmaceuticals to both companion animal and large animal markets in the U.S. and U.K.
Cornell Surgical Co is a Bergenfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tornier California is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.